Answers are grounded in this paper and cite their sources.
Figure S3. KRAS mutation is not associated with additional alterations to tumor immunogenicity
No takes yet. Share an insight, caveat, or question.
Principe et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: